Trial Profile
Phase I/II Multicenter, Open-label Trial to Evaluate the Safety and Pharmacokinetics of Alpha-1 MP in Patients with Alpha1-Antitrypsin Deficiency
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 22 Feb 2021
Price :
$35
*
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Alpha 1-antitrypsin deficiency
- Focus Adverse reactions
- Sponsors Grifols
- 18 Apr 2017 Status changed from recruiting to completed.
- 09 Jun 2016 New trial record